PRCT vs RXST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

PRCT

36.6
AI Score
VS
RXST Wins

RXST

49.2
AI Score

Investment Advisor Scores

PRCT

37score
Recommendation
AVOID NEW MONEY

RXST

49score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric PRCT RXST Winner
Forward P/E 0 116.2791 Tie
PEG Ratio 0 0 Tie
Revenue Growth 18.0% -19.0% PRCT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.6/100 49.2/100 RXST
Profit Margin -32.6% -43.8% PRCT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY BUY RXST

Relative Price Performance (Last 90 Days)

PRCT 1M: +34.3% · 3M: +8.6% RXST 1M: +19.0% · 3M: -21.9%

Current Technical Phase

PRCT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 68

RSI (14): 68.1 · Price: $23.51

RXST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.2 · Price: $5.38

Fundamentals Snapshot

Metric PRCT RXST
Market Cap — —
Forward P/E -19.1 -7.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.2% -0.2%
Gross Margin 0.6% 0.8%
Operating Margin -0.3% -0.5%
EPS -2.02 -1.29
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RXST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.